Cardiac resynchronization therapy in patients with heart failure and moderately reduced ejection fraction: Could it trigger a super-response?

CONCLUSIONS: Symptomatic HF patients on maximal optimized medical treatment who have LBBB and baseline LVEF 35-45% appeared to derive significant clinical and structural benefit from CRT. PMID: 31543195 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31543195?dopt=Abstract

Source: Indian Heart J - April 30, 2019 Category: Cardiology Authors: Tawfik Ghanem M, Allam LE, Samir Ahmed R Tags: Indian Heart J Source Type: research